Lv31
370 积分 2026-11-13 加入
[Treatment and new evidences in neuromyelitis optica spectrum disorder]
3分钟前
求助中
Neuromyelitis optica spectrum disorder in Latin America: a global data share initiative
6分钟前
已完结
Risk of hepatitis B and tuberculosis reactivation in patients with neuromyelitis optica spectrum disorder undergoing B cell depletion therapy
7分钟前
已完结
Comparison on the effect of seven drugs to prevent relapses of neuromyelitis optica spectrum disorders: A modeling analysis of literature aggregate data
12分钟前
已完结
The evolution and current status of anti-B-cell therapies in autoimmune neurologic diseases
13分钟前
求助中
ERRATUM
18分钟前
已完结
Recent advances in the treatment of neuromyelitis optica spectrum disorders
18分钟前
已完结
[Efficacy and Safety of Inebilizumab, an Anti-CD19 Monoclonal Antibody, for the Treatment of Neuromyelitis Optica Spectrum Disorder: Based on the N-MOmentum Trial]
18分钟前
求助中
Inebilizumab-cdon: USFDA Approved for the Treatment of NMOSD (Neuromyelitis Optica Spectrum Disorder)
18分钟前
已完结
皖公网安备34019202002308
